A growing industry is racing to engineer a solution to global warming using the absorbent power of the oceans.

Dozens of companies and academic groups are pitching the same theory: that sinking rocks, nutrients, crop waste or seaweed in ...

Four new funding proposals, totalling US$117.5 million, have been submitted for review Modifications received to U.S. Air Force Academy Cooperative Agreement Outside date for going-private transaction ...

Canada’s Fraser Institute says bans on hydraulic fracturing have led to billions of dollars’ worth of shale gas potential in both Nova Scotia and New Brunswick going undeveloped. In a new report, the ...

A new non-profit organization, Talon Ridge Raptor Institute, is set to make its debut in the Tri-Cities, focusing on the education and preservation of raptors and various bird species. The ...

Scotiabank promises to disclose energy finance ratio in 2026Weeks after leaving the UN-backed Net-Zero Banking Alliance, the Bank of Nova Scotia has promised to ... fund PFA forsikringsaktieselskab ...

That is why nova-Institute is proud to welcome Dr. Lars Börger as the new Co-CEO alongside with Michael Carus, the current CEO of nova-Institute. As a team, they will join forces to drive progress ...

Barclays analyst Christine Cho CFA downgraded Sunnova Energy International (NOVA – Research Report) to a Hold today and set a price target of $1.00. See what stocks are receiving Strong Buy ...

Lars Börger, Ph.D., has been appointed the new co-CEO of nova-Institute. Börger will serve as co-CEO alongside nova-Institute’s current CEO, Michael Carus. He officially started his role on March 1.

The Doha Film Institute (DFI) has unveiled the 49 projects across all formats that will be showcased at the 11th edition of its Qumra development and networking event in April. They include ...

Lars Börger will join nova-Institute as its new co-CEO on March 1, 2025. He will work alongside Michael Carus, the current CEO, to promote sustainability in the chemical and materials sectors.

Researchers at the University of Jyväskylä, in collaboration with the University of Turku's Institute of Biomedicine, University of Helsinki and Nova Hospital of Central Finland, have developed ...